Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet function and pharmacologic inhibition.

Rabih A Chaer1, Joseph A Graham, Leila Mureebe

  • 1Department of Surgery, Division of Vascular Surgery, New York Presbyterian Hospital, New York, NY 10034, USA.

Vascular and Endovascular Surgery
|September 9, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanical venous thrombectomy may provide a cost-effective treatment option for patients with iliofemoral deep vein thrombosis.

Journal of vascular surgery. Venous and lymphatic disorders·2026
Same author

Gaps in Incidence and Design of Peripheral Versus Coronary Artery Disease Clinical Trials.

The Journal of surgical research·2026
Same author

Socioeconomic Disadvantage Is Associated with Health Care Disparities in Mortality, Readmission and Long-Term Anticoagulation in Young Patients Following Submassive (Intermediate-Risk) Pulmonary Embolism.

Annals of vascular surgery·2026
Same author

Stenting for symptomatic left renal vein compression in patients with complex pelvic venous disease is safe on long-term follow-up.

Journal of vascular surgery. Venous and lymphatic disorders·2026
Same author

External validation of prognostic multivariable risk models for surgical site infections after open lower extremity revascularization for peripheral arterial disease.

Surgery·2026
Same author

Contrast-enhanced ultrasound microbubble uptake and abnormal plasma biomarkers are seen in patients with abdominal aortic aneurysms.

JVS-vascular science·2026
Same journal

Abdominal Aortic Aneurysm SAC Embolization Passing Through an Aortocaval Fistula.

Vascular and endovascular surgery·2026
Same journal

Hybrid Lower Extremity Revascularization Avoiding Groin Re-Exploration in a Morbidly Obese Patient With Acute Limb Ischemia After Failed Femoral-Popliteal PTFE Bypass: A Case Report and Literature Review.

Vascular and endovascular surgery·2026
Same journal

A Large Superior Gluteal Artery Pseudoaneurysm Masquerading as a Pelvic Mass: When Not to Biopsy.

Vascular and endovascular surgery·2026
Same journal

Total Laparoscopic Inferior Mesenteric Artery Clipping for Persistent Type II Endoleak Following EVAR: A Case Report and Review of Surgical Strategy.

Vascular and endovascular surgery·2026
Same journal

Predictors for Type 2 Endoleak Requiring Embolization: Large Inferior Mesenteric Artery, Multiple Lumbar Arteries, and Anticoagulation.

Vascular and endovascular surgery·2026
Same journal

Diagnosis and Treatment Strategies for Femoral Vein Extramembranous Cysts: A Case Analysis and Literature Review.

Vascular and endovascular surgery·2026
See all related articles

Platelets are key catalysts in blood clotting and vessel repair, not just scaffolding. New drugs targeting platelet function improve outcomes in procedures like percutaneous intervention.

Area of Science:

  • Cardiovascular Science
  • Hematology
  • Pharmacology

Background:

  • Platelets traditionally linked to hemostasis and bleeding disorders.
  • Increasingly recognized critical role in atherosclerosis and vascular procedures.
  • Evolving understanding of platelets as active catalysts, not passive scaffolding.

Purpose of the Study:

  • To review platelet physiology.
  • To discuss the impact of novel pharmacologic agents.
  • To highlight advancements in percutaneous intervention.

Main Methods:

  • Literature review of platelet function.
  • Analysis of current pharmacological interventions.
  • Examination of outcomes in percutaneous coronary intervention.

Related Experiment Videos

Main Results:

  • Platelets are central to hemostasis, thrombosis, and fibrinolysis.
  • Pharmacologic advancements enhance patency rates.
  • Improved patient outcomes are associated with new antiplatelet therapies.

Conclusions:

  • Platelet function is crucial in cardiovascular disease and interventions.
  • Pharmacologic agents targeting platelets significantly improve procedural success.
  • Further research into platelet physiology will yield better therapeutic strategies.